Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This is an exploratory single-center prospective study of 20 subjects with primary basal
ganglia ICH who will receive early MIPS in combination with perioperative pioglitazone
treatment. Outcomes will be compared to matched subjects with basal ganglia ICH who undergo
MIPS alone as part of the ENRICH trial. This study will take approximately two years to
complete.